MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

+ final resuls and trials +

  1. 22,691 Posts.
    Obviously, if one spends on Research and trials but get little income then one will run a loss.

    Nothing unusual about that, but there are 2 items which matter: What is the present cash position? Anw.: $14 mill.

    What is the state with research and trials?



    And what are they going to do now?

    Shareholder Update of 28 July 2003:


    1. Phase 2B trial of the obesity drug AOD 9604 -Three hundred patients to take part. Duration: Three months.

    Patient screening is scheduled to start in September 2003 and the first patient is expected to commence treatment in October 2003.

    2. From the FDA boss, mr McClellan:

    “…. one key part of the FDA’s new medical innovation initiative is to try to facilitate the development of better treatments for obesity and diabetes. These are areas where we think regulatory pathways could be improved or better defined, and where we intend to give priority attention to potentially valuable new products.

    3. Favourable toxicity draft reports
    Draft reports on 3 month toxicity studies in monkeys and rats have been received and are favourable.

    Every man and his dog have applied to be enrolled but they only need 300 patients. Phase II trial to start in Oct. and duration is for 3 months only.

    Ii is the last part I like: "3 months only".

    If the results are good then most likely a partner will be approached to carry out the commercial arrangements, including Phase III.

    As mentioned, the FDA is very interested in obesity and with the good relationship MBP has with the FDA, it is possible that FDA may grant a shortcut: Start commercialisation after Phase II and complete Phase III after.

    I can't promise anything but there is a very good chance it will happen.

    So, with the cash in hand and an important trial on their footstep, exciting times to come!

    Please do your own research and you decide if and when to buy, hold or sell any stocks.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.